Medication news 2003
American researchers
seek approval for drug implant (10/06/03)
Zyprexa gets warning
label (09/23/03)
FDA approves new supplement for treatment
of schizophrenic patients (09/17/03)
Orally administered olanzapine may be
used to treat agitated schizophrenia patients (09/09/03)
New evidence that
new antispychotic medications can increase the risk for diabetes
(08/28/03)
More and more children on antipsychotic
medications (08/15/03)
Schizophrenia
drugs linked to diabetes (06/05/03)
And the debate
goes on... (05/23/03)
Are newer antipsychotic drugs better
than the older ones? (05/13/03)
Fast-dissolving form of Risperdal
released (05/13/03)
American
researchers seek approval for drug implant (10/06/03)
Researchers in the US are about to seek FDA approval of a surgically
implanted tablet that could deliver daily doses of psychiatric medication
for as long as a year. The implant is biodegradable and about 1
centimeter in diameter and 1 millimeter thick. The implant, which
could contain antidepressants as well as other medications, gradually
disappears over the course of a year, slowly releasing the drug.
If the patient has to be taken off the drug, the effects immediately
cease when the tablet is removed.
Source: The Boston Globe, Friday, September 26, 2003
Read
more in article at www.boston.com
Zyprexa gets
warning label (09/23/03)
 Because
of indications from a number of studies, that several new antipsychotic
medications are associated with an increased risk for diabetes,
pharmaceutical company Eli Lilly and Co. now have to post a warning
of a diabetes risk on its best-selling drug Zyprexa.
Source: Indystar.com, Tuesday, September 18, 2003
Read
more in article at www.indystar.com
FDA approves
new supplement for treatment of schizophrenic patients (09/17/03)
The US Food and Drug Administration (FDA) has approved a Supplemental
New Drug Application (sNDA) for Abilify™ (aripiprazole) for
treatment of patients with schizophrenia.
Source: Doctor's Guide, Tuesday, September 9, 2003
Read
more in article at www.docguide.com
Orally administered
olanzapine may be used to treat agitated schizophrenia patients
(09/09/03)
Olanzapine is anantipsychotic medication that is often used to treat
schizophrenia and bipolar disorder. Agitated patients are usually
treated with a typical antipsychotic drug such as haloperidol, which
is then replaced with olanzapine or another atypical antipsychotic
after the acute stabilisation phase. Now researchers have found
that a rapid initial high dose of oral olanzapine may be useful
in treating agitated schizophrenics or patients with bipolar disorder.
Source: Doctor's Guide, Friday, August 29, 2003
Read
more in article at www.docguide.com
New evidence
that new antispychotic medications can increase the risk for diabetes
(08/28/03)
Previous research has shown that newer antipsychotic medications
may increase the risk for diabetes. Now an American study supports
these indications, showing that three commonly used drugs, Eli Lilly’s
Zyprexa, Jannsen Pharmaceutica’s Risperdal, and Astra Zeneca’s
Seroquel, are all associated with a higher rates of diabetes in
the patients than older drugs like Haldol.
Source: New York Times, Monday, August 25, 2003
Read
more in article at www.nytimes.com
More and
more children on antipsychotic medications (08/15/03)
The development of better diagnosis methods have led to the possibility
of diagnosing psychiatric diseases at an earlier age. This, in turn,
means doctors are prescribing antipsychotic medications to more
and more children.
Source: Seattle Times, Wednesday, August 13, 2003
Läs
mer i artikel på www.seattletimes.nwsource.com
Schizophrenia
drugs linked to diabetes (06/05/03)
Research shows that newer antipsychotics can elevate blood sugar
levels, which may lead to diabetes. Of the 121 people with schizophrenia
that were investigated in a study at Yale, almost 25% developed
high blood sugar levels while taking Clozaril.
Source: WebMD, Tuesday, June 3, 2003
Read
more in article at www.webmd.com
And the debate
goes on... (05/23/03)
 How
superior are the new antipsychotics? And balancing side effects
and cost, are they really that much advantageous than older antispychotic
medications? An extensive article in NY Times discusses the issue.
Source: NY Times, Friday, May 23, 2003
Read
more in article at www.nytimes.com
Fulltext
article in PDF format
Are newer
antipsychotic drugs better than the older ones? (05/13/03)
 Newer
antipsychotics are considered to be superior to older antispychotic
drugs - more efficient and with fewer side effects. Now current
reports say this may not be completely true.
Source: BBC News and WebMD, Thursday, May 8-9, 2003
Read
more in article at www.bbc.co.uk
Read
more in article at www.webmd.com
Fast-dissolving
form of Risperdal released (05/13/03)
Risperdal® (risperidone), marketed by Janssen Pharmaceutica
Products, L.P., is the most widely prescribed antipsychotic medication
in the US. Now the drug is released as a fast-dissolving form of
schizophrenia medication, Risperdal M-TAB™, which dissolves
in seconds when placed on the tongue.
Source: Doctor's Guide, Tuesday,
May 6, 2003
Read
more in articel at www.docnews.com
To the medications
index page
Medication
news from 2005
Medication news from
2004
Medication news from
2002
Medication
news from 2001
To the top of the page
|
